Maximus, Inc. (NYSE:MMS – Get Free Report) Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The stock was acquired at an average price of $71.46 per share, with a total value of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.
Maximus Price Performance
Shares of MMS stock opened at $69.81 on Friday. The business’s 50 day moving average price is $82.58 and its 200-day moving average price is $86.60. Maximus, Inc. has a fifty-two week low of $69.72 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The firm has a market cap of $4.21 billion, a P/E ratio of 13.96 and a beta of 0.73.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. Maximus’s dividend payout ratio is currently 24.00%.
Institutional Investors Weigh In On Maximus
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.
View Our Latest Analysis on MMS
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- Where Do I Find 52-Week Highs and Lows?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Do ETFs Pay Dividends? What You Need to Know
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Earnings Reports?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.